×

PMDA

shutterstock_552100717

Japan renews its participation in MDSAP until 2020

By Luis Jimenez | 05.02.2019
Japan’s participation in MDSAP (Medical Device Standardized Audit Program) has been a contributing factor in the exponential update of MDSAP by multinational companies. Japan’s MHLW and PMDA has been opting...
Brandwood Biomedical global experts medical devices regulatory affairs consulting medical devices IVDs Brandwood Biomedical Global Expertise in Medical Device Regulatory Compliance Australia China Taiwan Hong Kong Europe New Zealand United States

Australia via 510(k): TGA – recognises US, Canadian and Japanese approvals with MDSAP

By Arthur Brandwood | 08.30.2018
Australia’s regulatory system is modelled very closely on that of Europe. This equivalence of requirements and assessment pathways has allowed TGA to leverage prior CE marking to grant Australian device...

Search

Recent Posts

A single review program for medical devices?

Dec 2, 2019

The door to Europe is closed – so where else should I look?

Dec 2, 2019

Are Harmonised Standards facing irrelevance?

Nov 4, 2019

The question on clients’ lips… “How long will my application take?”

Nov 4, 2019

TGA Publishes updated MDIR Guide

Oct 31, 2019

EU Software Classification under MDR/IVDR – New Guidance Document

Oct 28, 2019

Categories

Categories

Archives

Archives

Archives

Tags

3D 3D printing 510(k) APAC Australia Biocompatibility Biomechanics Brexit CE CE Certificates CFDA clinical trials de novo distribution Europe FDA GHTF guidance Harmonization IMDRF IVD IVDR MDD MDR MDSAP mechanical properties medical device medical devices medicines New Zealand Notified Bodies PMA PMDA postmarket private health insurance QMS Quality Systems Reform Reimbursement SaMD Software standards Sterilisation TGA UDI
Translate »